Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Total Current Liabilities (2022 - 2025)

Neuraxis' Total Current Liabilities history spans 4 years, with the latest figure at $3.1 million for Q3 2025.

  • For Q3 2025, Total Current Liabilities rose 18.13% year-over-year to $3.1 million; the TTM value through Sep 2025 reached $3.1 million, up 18.13%, while the annual FY2024 figure was $2.4 million, 29.04% up from the prior year.
  • Total Current Liabilities for Q3 2025 was $3.1 million at Neuraxis, up from $2.3 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $11.4 million in Q2 2023 and bottomed at $1.9 million in Q4 2023.
  • The 4-year median for Total Current Liabilities is $2.7 million (2024), against an average of $4.2 million.
  • The largest annual shift saw Total Current Liabilities plummeted 72.98% in 2023 before it grew 29.04% in 2024.
  • A 4-year view of Total Current Liabilities shows it stood at $7.0 million in 2022, then tumbled by 72.98% to $1.9 million in 2023, then rose by 29.04% to $2.4 million in 2024, then rose by 29.34% to $3.1 million in 2025.
  • Per Business Quant, the three most recent readings for NRXS's Total Current Liabilities are $3.1 million (Q3 2025), $2.3 million (Q2 2025), and $2.1 million (Q1 2025).